甲状腺自身抗体及其在AITD中的致病作用

被引:29
作者
李连喜
罗敏
机构
[1] 上海第二医科大学附属瑞金医院
[2] 上海市内分泌研究所!上海
关键词
自身免疫性甲状腺疾病; 自身抗体;
D O I
暂无
中图分类号
R581.02 [];
学科分类号
1002 ; 100201 ;
摘要
自身免疫性甲状腺疾病 (AITD)患者体内存在多种甲状腺自身抗体 ,比较明确的有甲状腺球蛋白抗体(TGAb)、促甲状腺激素受体抗体 (TRAb)、甲状腺过氧化物酶抗体 (TPOAb) ,近年又发现一些新的甲状腺自身抗体如抗钠 /碘同向转运体抗体、抗GP330抗体、抗Gal抗体、抗G2s抗体等。另有许多抗体如抗热休克蛋白抗体等的性质、作用尚不明确 ,文中详述TGAb、TRAb、TPOAb及其致病作用 ,并对其他抗体及可能的致病作用作简要综述。
引用
收藏
页码:65 / 67
页数:3
相关论文
共 14 条
[1]  
Autoimmune thyroid disease:further developments in our understanding. Weetman A P,McGregor A M. Endocrine Reviews . 1994
[2]  
Thyrotropin prevents apoptosis by promoting cell adhesion and cell cycle progression in FRTL-5 cells. Li X,Lu S,Miyagi E,et al. The Journal of Endocrinology . 1999
[3]  
The antibody response in human autoimmune thyroid disease. McIntosh R S,Asghar M S,Weetman A P. Clinical Science Colch . 1997
[4]  
The nature of autoantigens targeted in autoimmune endocrine diseases. Song Y H,Li Y X,Maclaren N K. Immunology Today . 1996
[5]  
Serum Antibodies against megalin(GP330) in patients with autoimmune thyroiditis. Marino M,Chiovato L,Friedlander J A,et al. The Journal of Clinical Endocrinology . 1999
[6]  
Pathogenesisofautoimmunethy roiddisease. AjjanRA,WeetmanAP. . 1999
[7]  
Catalytic activity of antithyroglobulin antibodies. Li L,Paul S,Tyutyulkova S,et al. J Immunol . 1995
[8]  
Autoantibody against Na+ /I- symporter in the sera of patients with autoimmune thyroid disease. Endo T,Kogai T,Nakazato M,et al. Biochemical and Biophysical Research Communications . 1996
[9]  
Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves′hyperthyroidism. Gunji K,Bellis A,Li A Y,et al. The Journal of Clinical Endocrinology . 2000
[10]  
Elevated antigalactosyl antibody titer in endemic goiter. Knobel M,Umezawa E S,Cardia M S,et al. Thyroid . 1999